Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Innerarity

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Investigation|November 1, 1981
Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptorsR W Mahley, D Y Hui, T L Innerarity, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residuesR W Mahley, K H Weisgraber, T L Innerarity, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Apolipoprotein E: receptor binding propertiesK H Weisgraber, T L Innerarity, S C Rall, et al.
JAMA|January 12, 1991
Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolismR W Mahley, K H Weisgraber, T L Innerarity, et al.
Arteriosclerosis (Dallas, Tex.)|January 1, 1986
Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophagesT L Innerarity, K S Arnold, K H Weisgraber, et al.
Genome Research|November 1, 1996
A simple and efficient method for making site-directed mutants, deletions, and fusions of large DNA such as P1 and BAC clonesJ Borén, I Lee, M J Callow, et al.
Lancet (London, England)|October 14, 1978
Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterolR W Mahley, T L Innerarity, T P Bersot, et al.
The Journal of Clinical Investigation|April 16, 1998
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100J Boren, I Lee, W Zhu, et al.
The Journal of Clinical Investigation|June 24, 1998
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor bindingJ Borén, K Olin, I Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 1998
Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumorsX Qian, M E Balestra, S Yamanaka, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Investigation|November 1, 1981
Two independent lipoprotein receptors on hepatic membranes of dog, swine, and man. Apo-B,E and apo-E receptorsR W Mahley, D Y Hui, T L Innerarity, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1979
Accelerated clearance of low-density and high-density lipoproteins and retarded clearance of E apoprotein-containing lipoproteins from the plasma of rats after modification of lysine residuesR W Mahley, K H Weisgraber, T L Innerarity, et al.
Advances in Experimental Medicine and Biology|January 1, 1985
Apolipoprotein E: receptor binding propertiesK H Weisgraber, T L Innerarity, S C Rall, et al.
JAMA|January 12, 1991
Genetic defects in lipoprotein metabolism. Elevation of atherogenic lipoproteins caused by impaired catabolismR W Mahley, K H Weisgraber, T L Innerarity, et al.
Arteriosclerosis (Dallas, Tex.)|January 1, 1986
Apolipoprotein E is the determinant that mediates the receptor uptake of beta-very low density lipoproteins by mouse macrophagesT L Innerarity, K S Arnold, K H Weisgraber, et al.
Genome Research|November 1, 1996
A simple and efficient method for making site-directed mutants, deletions, and fusions of large DNA such as P1 and BAC clonesJ Borén, I Lee, M J Callow, et al.
Lancet (London, England)|October 14, 1978
Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterolR W Mahley, T L Innerarity, T P Bersot, et al.
The Journal of Clinical Investigation|April 16, 1998
Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100J Boren, I Lee, W Zhu, et al.
The Journal of Clinical Investigation|June 24, 1998
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor bindingJ Borén, K Olin, I Lee, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 20, 1998
Low expression of the apolipoprotein B mRNA-editing transgene in mice reduces LDL levels but does not cause liver dysplasia or tumorsX Qian, M E Balestra, S Yamanaka, et al.
Pageof 11